Cargando…
Measuring Surgery Outcomes of Lung Cancer Patients with Concomitant Pulmonary Fibrosis: A Review of the Literature
Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial pneumonias, often progresses to restrictive respiratory disturbance and mortality, typically within 10 years. IPF frequently coexists with lung cancer, and the combination of these two disease entities is far more d...
Autor principal: | Goto, Taichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070817/ https://www.ncbi.nlm.nih.gov/pubmed/29973551 http://dx.doi.org/10.3390/cancers10070223 |
Ejemplares similares
-
Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review
por: Kinoshita, Tomonari, et al.
Publicado: (2019) -
Airway Microbiota as a Modulator of Lung Cancer
por: Goto, Taichiro
Publicado: (2020) -
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019) -
Impact of coronavirus disease pandemic on surgery for lung cancer in a provincial city in Japan
por: Goto, Taichiro
Publicado: (2020) -
Safety of Postoperative Administration of Human Urinary Trypsin Inhibitor in Lung Cancer Patients with Idiopathic Pulmonary Fibrosis
por: Yamauchi, Yoshikane, et al.
Publicado: (2011)